Bioethics

Bioethics Net Debt/FCF

The Net Debt to Free Cash Flow Ratio of Bioethics (BOTH) as of Oct 22, 2026 is -19.85. In the previous year, Net Debt to Free Cash Flow Ratio was -16.42 — a change of 20.89% (lower).

Net Debt/FCF

-19.85

YoY

20.89%

Last updated:

Net Debt to Free Cash Flow Ratio of Bioethics is 2023 -19.85 . Net Debt to Free Cash Flow Ratio of Bioethics was 2022 -16.42 . It decreases by 20.89% lower compared to the previous year.

The Bioethics Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2016
-2.15 USD
Jan 1, 2017
-2.32 USD
Jan 1, 2018
-4.98 USD
Jan 1, 2019
-3.72 USD
Jan 1, 2020
-5.30 USD
Jan 1, 2021
-14.35 USD
Jan 1, 2022
-16.42 USD
Jan 1, 2023
-19.85 USD
The Bioethics Net Debt/FCF history
YEARNet Debt/FCFYoY
-19.85+20.89%
-16.42+14.39%
-14.35+170.59%
-5.30+42.73%
-3.72-25.40%
-4.98+114.58%
-2.32+7.82%
-2.15+89.25%
-1.14+153.89%
-0.45—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioethics Stock analysis

What does Bioethics do? Bioethics Ltd. is a shell company with no operations or revenue. The company has no full-time employees and is formed to pursue a merger, share exchange, asset acquisition, or similar business combination with another entity. It has not identified any specific target for such a transaction and has not engaged in any substantive discussions with potential partners. The firm remains inactive without generating any income from operations. Bioethics Ltd. does not sell any products or services. It is structured as a vehicle for future business combinations, with no current business activities or revenue streams. The company's purpose is limited to seeking a merger or acquisition target, and it has not yet entered into any agreements or initiated any operational activities. There are no brands, customers, or segments associated with its current status. The firm is headquartered in Ogden, Utah, but this location is not used for any operational purposes. Bioethics Ltd. has no employees, no revenue, and no business activities beyond the formation of the shell company itself. It has not generated any income or engaged in any transactions that would produce revenue. Bioethics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioethics stock

Net Debt to Free Cash Flow Ratio of Bioethics is -19.85 in 2023.

Net Debt to Free Cash Flow Ratio of Bioethics changed from -16.42 to -19.85, representing a 20.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio Bioethics since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's Bioethics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Bioethics

All Key Metrics — Bioethics